Global PD-1 and PD-L1 Inhibitors Market Research Report 2020
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the PD-1 and PD-L1 Inhibitors market is segmented into
The PD-1 and PD-L1 Inhibitors market is analysed and market size information is provided by regions (countries).
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the PD-1 and PD-L1 Inhibitors market report are:
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global PD-1 and PD-L1 Inhibitors market include:
Segment by Type, the PD-1 and PD-L1 Inhibitors market is segmented into
- PD-1 Inhibitors
- PD-L1 Inhibitors
- Solid Tumors
- Blood-related Tumors
The PD-1 and PD-L1 Inhibitors market is analysed and market size information is provided by regions (countries).
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the PD-1 and PD-L1 Inhibitors market report are:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global PD-1 and PD-L1 Inhibitors market include:
- Merck
- Bristol-Myers Squibb
- Roche
- AstraZeneca
- Ono Pharmaceutical
- Regeneron
- Innovent
- Hengrui Medicine
- Junshi Biosciences
- Merck KGaA
1 PD-1 AND PD-L1 INHIBITORS MARKET OVERVIEW
1.1 Product Overview and Scope of PD-1 and PD-L1 Inhibitors
1.2 PD-1 and PD-L1 Inhibitors Segment by Type
1.2.1 Global PD-1 and PD-L1 Inhibitors Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 PD-1 Inhibitors
1.2.3 PD-L1 Inhibitors
1.3 PD-1 and PD-L1 Inhibitors Segment by Application
1.3.1 PD-1 and PD-L1 Inhibitors Sales Comparison by Application: 2020 VS 2026
1.3.2 Solid Tumors
1.3.3 Blood-related Tumors
1.4 Global PD-1 and PD-L1 Inhibitors Market Size Estimates and Forecasts
1.4.1 Global PD-1 and PD-L1 Inhibitors Revenue 2015-2026
1.4.2 Global PD-1 and PD-L1 Inhibitors Sales 2015-2026
1.4.3 PD-1 and PD-L1 Inhibitors Market Size by Region: 2020 Versus 2026
1.5 PD-1 and PD-L1 Inhibitors Industry
1.6 PD-1 and PD-L1 Inhibitors Market Trends
2 GLOBAL PD-1 AND PD-L1 INHIBITORS MARKET COMPETITION BY MANUFACTURERS
2.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Manufacturers (2015-2020)
2.2 Global PD-1 and PD-L1 Inhibitors Revenue Share by Manufacturers (2015-2020)
2.3 Global PD-1 and PD-L1 Inhibitors Average Price by Manufacturers (2015-2020)
2.4 Manufacturers PD-1 and PD-L1 Inhibitors Manufacturing Sites, Area Served, Product Type
2.5 PD-1 and PD-L1 Inhibitors Market Competitive Situation and Trends
2.5.1 PD-1 and PD-L1 Inhibitors Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key PD-1 and PD-L1 Inhibitors Players (Opinion Leaders)
3 PD-1 AND PD-L1 INHIBITORS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global PD-1 and PD-L1 Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global PD-1 and PD-L1 Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
3.3.1 North America PD-1 and PD-L1 Inhibitors Sales by Country
3.3.2 North America PD-1 and PD-L1 Inhibitors Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
3.4.1 Europe PD-1 and PD-L1 Inhibitors Sales by Country
3.4.2 Europe PD-1 and PD-L1 Inhibitors Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific PD-1 and PD-L1 Inhibitors Market Facts & Figures by Region
3.5.1 Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Region
3.5.2 Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
3.6.1 Latin America PD-1 and PD-L1 Inhibitors Sales by Country
3.6.2 Latin America PD-1 and PD-L1 Inhibitors Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
3.7.1 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country
3.7.2 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 GLOBAL PD-1 AND PD-L1 INHIBITORS HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
4.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2015-2020)
4.3 Global PD-1 and PD-L1 Inhibitors Price Market Share by Type (2015-2020)
4.4 Global PD-1 and PD-L1 Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL PD-1 AND PD-L1 INHIBITORS HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
5.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2015-2020)
5.3 Global PD-1 and PD-L1 Inhibitors Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN PD-1 AND PD-L1 INHIBITORS BUSINESS
6.1 Merck
6.1.1 Corporation Information
6.1.2 Merck Description, Business Overview and Total Revenue
6.1.3 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Merck Products Offered
6.1.5 Merck Recent Development
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Corporation Information
6.2.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
6.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Bristol-Myers Squibb Products Offered
6.2.5 Bristol-Myers Squibb Recent Development
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description, Business Overview and Total Revenue
6.3.3 Roche PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Roche Products Offered
6.3.5 Roche Recent Development
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description, Business Overview and Total Revenue
6.4.3 AstraZeneca PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.4.4 AstraZeneca Products Offered
6.4.5 AstraZeneca Recent Development
6.5 Ono Pharmaceutical
6.5.1 Ono Pharmaceutical Corporation Information
6.5.2 Ono Pharmaceutical Description, Business Overview and Total Revenue
6.5.3 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Ono Pharmaceutical Products Offered
6.5.5 Ono Pharmaceutical Recent Development
6.6 Regeneron
6.6.1 Regeneron Corporation Information
6.6.2 Regeneron Description, Business Overview and Total Revenue
6.6.3 Regeneron PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Regeneron Products Offered
6.6.5 Regeneron Recent Development
6.7 Innovent
6.6.1 Innovent Corporation Information
6.6.2 Innovent Description, Business Overview and Total Revenue
6.6.3 Innovent PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Innovent Products Offered
6.7.5 Innovent Recent Development
6.8 Hengrui Medicine
6.8.1 Hengrui Medicine Corporation Information
6.8.2 Hengrui Medicine Description, Business Overview and Total Revenue
6.8.3 Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Hengrui Medicine Products Offered
6.8.5 Hengrui Medicine Recent Development
6.9 Junshi Biosciences
6.9.1 Junshi Biosciences Corporation Information
6.9.2 Junshi Biosciences Description, Business Overview and Total Revenue
6.9.3 Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Junshi Biosciences Products Offered
6.9.5 Junshi Biosciences Recent Development
6.10 Merck KGaA
6.10.1 Merck KGaA Corporation Information
6.10.2 Merck KGaA Description, Business Overview and Total Revenue
6.10.3 Merck KGaA PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Merck KGaA Products Offered
6.10.5 Merck KGaA Recent Development
7 PD-1 AND PD-L1 INHIBITORS MANUFACTURING COST ANALYSIS
7.1 PD-1 and PD-L1 Inhibitors Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
7.4 PD-1 and PD-L1 Inhibitors Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 PD-1 and PD-L1 Inhibitors Distributors List
8.3 PD-1 and PD-L1 Inhibitors Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global PD-1 and PD-L1 Inhibitors Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of PD-1 and PD-L1 Inhibitors by Type (2021-2026)
10.1.2 Global Forecasted Revenue of PD-1 and PD-L1 Inhibitors by Type (2021-2026)
10.2 PD-1 and PD-L1 Inhibitors Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of PD-1 and PD-L1 Inhibitors by Application (2021-2026)
10.2.2 Global Forecasted Revenue of PD-1 and PD-L1 Inhibitors by Application (2021-2026)
10.3 PD-1 and PD-L1 Inhibitors Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of PD-1 and PD-L1 Inhibitors by Region (2021-2026)
10.3.2 Global Forecasted Revenue of PD-1 and PD-L1 Inhibitors by Region (2021-2026)
10.4 North America PD-1 and PD-L1 Inhibitors Estimates and Projections (2021-2026)
10.5 Europe PD-1 and PD-L1 Inhibitors Estimates and Projections (2021-2026)
10.6 Asia Pacific PD-1 and PD-L1 Inhibitors Estimates and Projections (2021-2026)
10.7 Latin America PD-1 and PD-L1 Inhibitors Estimates and Projections (2021-2026)
10.8 Middle East and Africa PD-1 and PD-L1 Inhibitors Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
1.1 Product Overview and Scope of PD-1 and PD-L1 Inhibitors
1.2 PD-1 and PD-L1 Inhibitors Segment by Type
1.2.1 Global PD-1 and PD-L1 Inhibitors Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 PD-1 Inhibitors
1.2.3 PD-L1 Inhibitors
1.3 PD-1 and PD-L1 Inhibitors Segment by Application
1.3.1 PD-1 and PD-L1 Inhibitors Sales Comparison by Application: 2020 VS 2026
1.3.2 Solid Tumors
1.3.3 Blood-related Tumors
1.4 Global PD-1 and PD-L1 Inhibitors Market Size Estimates and Forecasts
1.4.1 Global PD-1 and PD-L1 Inhibitors Revenue 2015-2026
1.4.2 Global PD-1 and PD-L1 Inhibitors Sales 2015-2026
1.4.3 PD-1 and PD-L1 Inhibitors Market Size by Region: 2020 Versus 2026
1.5 PD-1 and PD-L1 Inhibitors Industry
1.6 PD-1 and PD-L1 Inhibitors Market Trends
2 GLOBAL PD-1 AND PD-L1 INHIBITORS MARKET COMPETITION BY MANUFACTURERS
2.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Manufacturers (2015-2020)
2.2 Global PD-1 and PD-L1 Inhibitors Revenue Share by Manufacturers (2015-2020)
2.3 Global PD-1 and PD-L1 Inhibitors Average Price by Manufacturers (2015-2020)
2.4 Manufacturers PD-1 and PD-L1 Inhibitors Manufacturing Sites, Area Served, Product Type
2.5 PD-1 and PD-L1 Inhibitors Market Competitive Situation and Trends
2.5.1 PD-1 and PD-L1 Inhibitors Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key PD-1 and PD-L1 Inhibitors Players (Opinion Leaders)
3 PD-1 AND PD-L1 INHIBITORS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global PD-1 and PD-L1 Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global PD-1 and PD-L1 Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
3.3.1 North America PD-1 and PD-L1 Inhibitors Sales by Country
3.3.2 North America PD-1 and PD-L1 Inhibitors Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
3.4.1 Europe PD-1 and PD-L1 Inhibitors Sales by Country
3.4.2 Europe PD-1 and PD-L1 Inhibitors Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific PD-1 and PD-L1 Inhibitors Market Facts & Figures by Region
3.5.1 Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Region
3.5.2 Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
3.6.1 Latin America PD-1 and PD-L1 Inhibitors Sales by Country
3.6.2 Latin America PD-1 and PD-L1 Inhibitors Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
3.7.1 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country
3.7.2 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 GLOBAL PD-1 AND PD-L1 INHIBITORS HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
4.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2015-2020)
4.3 Global PD-1 and PD-L1 Inhibitors Price Market Share by Type (2015-2020)
4.4 Global PD-1 and PD-L1 Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL PD-1 AND PD-L1 INHIBITORS HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
5.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2015-2020)
5.3 Global PD-1 and PD-L1 Inhibitors Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN PD-1 AND PD-L1 INHIBITORS BUSINESS
6.1 Merck
6.1.1 Corporation Information
6.1.2 Merck Description, Business Overview and Total Revenue
6.1.3 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Merck Products Offered
6.1.5 Merck Recent Development
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Corporation Information
6.2.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
6.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Bristol-Myers Squibb Products Offered
6.2.5 Bristol-Myers Squibb Recent Development
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description, Business Overview and Total Revenue
6.3.3 Roche PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Roche Products Offered
6.3.5 Roche Recent Development
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description, Business Overview and Total Revenue
6.4.3 AstraZeneca PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.4.4 AstraZeneca Products Offered
6.4.5 AstraZeneca Recent Development
6.5 Ono Pharmaceutical
6.5.1 Ono Pharmaceutical Corporation Information
6.5.2 Ono Pharmaceutical Description, Business Overview and Total Revenue
6.5.3 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Ono Pharmaceutical Products Offered
6.5.5 Ono Pharmaceutical Recent Development
6.6 Regeneron
6.6.1 Regeneron Corporation Information
6.6.2 Regeneron Description, Business Overview and Total Revenue
6.6.3 Regeneron PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Regeneron Products Offered
6.6.5 Regeneron Recent Development
6.7 Innovent
6.6.1 Innovent Corporation Information
6.6.2 Innovent Description, Business Overview and Total Revenue
6.6.3 Innovent PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Innovent Products Offered
6.7.5 Innovent Recent Development
6.8 Hengrui Medicine
6.8.1 Hengrui Medicine Corporation Information
6.8.2 Hengrui Medicine Description, Business Overview and Total Revenue
6.8.3 Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Hengrui Medicine Products Offered
6.8.5 Hengrui Medicine Recent Development
6.9 Junshi Biosciences
6.9.1 Junshi Biosciences Corporation Information
6.9.2 Junshi Biosciences Description, Business Overview and Total Revenue
6.9.3 Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Junshi Biosciences Products Offered
6.9.5 Junshi Biosciences Recent Development
6.10 Merck KGaA
6.10.1 Merck KGaA Corporation Information
6.10.2 Merck KGaA Description, Business Overview and Total Revenue
6.10.3 Merck KGaA PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Merck KGaA Products Offered
6.10.5 Merck KGaA Recent Development
7 PD-1 AND PD-L1 INHIBITORS MANUFACTURING COST ANALYSIS
7.1 PD-1 and PD-L1 Inhibitors Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
7.4 PD-1 and PD-L1 Inhibitors Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 PD-1 and PD-L1 Inhibitors Distributors List
8.3 PD-1 and PD-L1 Inhibitors Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global PD-1 and PD-L1 Inhibitors Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of PD-1 and PD-L1 Inhibitors by Type (2021-2026)
10.1.2 Global Forecasted Revenue of PD-1 and PD-L1 Inhibitors by Type (2021-2026)
10.2 PD-1 and PD-L1 Inhibitors Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of PD-1 and PD-L1 Inhibitors by Application (2021-2026)
10.2.2 Global Forecasted Revenue of PD-1 and PD-L1 Inhibitors by Application (2021-2026)
10.3 PD-1 and PD-L1 Inhibitors Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of PD-1 and PD-L1 Inhibitors by Region (2021-2026)
10.3.2 Global Forecasted Revenue of PD-1 and PD-L1 Inhibitors by Region (2021-2026)
10.4 North America PD-1 and PD-L1 Inhibitors Estimates and Projections (2021-2026)
10.5 Europe PD-1 and PD-L1 Inhibitors Estimates and Projections (2021-2026)
10.6 Asia Pacific PD-1 and PD-L1 Inhibitors Estimates and Projections (2021-2026)
10.7 Latin America PD-1 and PD-L1 Inhibitors Estimates and Projections (2021-2026)
10.8 Middle East and Africa PD-1 and PD-L1 Inhibitors Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES
Table 1. Global PD-1 and PD-L1 Inhibitors Sales (L) Growth Rate Comparison by Type (2015-2026)
Table 2. Global PD-1 and PD-L1 Inhibitors Sales (L) Comparison by Application: 2020 VS 2026
Table 3. Global PD-1 and PD-L1 Inhibitors Market Size by Type (L) (US$ Million) (2020 VS 2026)
Table 4. Global Key PD-1 and PD-L1 Inhibitors Manufacturers Covered in This Study
Table 5. Global PD-1 and PD-L1 Inhibitors Sales (L) by Manufacturers (2015-2020)
Table 6. Global PD-1 and PD-L1 Inhibitors Sales Share by Manufacturers (2015-2020)
Table 7. Global PD-1 and PD-L1 Inhibitors Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global PD-1 and PD-L1 Inhibitors Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market PD-1 and PD-L1 Inhibitors Average Price (USD/ml) of Key Manufacturers (2015-2020)
Table 10. Manufacturers PD-1 and PD-L1 Inhibitors Sales Sites and Area Served
Table 11. Manufacturers PD-1 and PD-L1 Inhibitors Product Types
Table 12. Global PD-1 and PD-L1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global PD-1 and PD-L1 Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-1 and PD-L1 Inhibitors as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key PD-1 and PD-L1 Inhibitors Players
Table 16. Global PD-1 and PD-L1 Inhibitors Sales (L) by Region (2015-2020)
Table 17. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2015-2020)
Table 18. Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) by Region (2015-2020)
Table 19. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2015-2020)
Table 20. North America PD-1 and PD-L1 Inhibitors Sales by Country (2015-2020) (L)
Table 21. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2015-2020)
Table 22. North America PD-1 and PD-L1 Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 23. North America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2015-2020)
Table 24. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2015-2020) (L)
Table 25. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2015-2020)
Table 26. Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Region (2015-2020) (L)
Table 29. Asia Pacific PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2015-2020)
Table 32. Latin America PD-1 and PD-L1 Inhibitors Sales by Country (2015-2020) (L)
Table 33. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2015-2020)
Table 34. Latin America PD-1 and PD-L1 Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country (2015-2020) (L)
Table 37. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2015-2020)
Table 40. Global PD-1 and PD-L1 Inhibitors Sales (L) by Type (2015-2020)
Table 41. Global PD-1 and PD-L1 Inhibitors Sales Share by Type (2015-2020)
Table 42. Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) by Type (2015-2020)
Table 43. Global PD-1 and PD-L1 Inhibitors Revenue Share by Type (2015-2020)
Table 44. Global PD-1 and PD-L1 Inhibitors Price (USD/ml) by Type (2015-2020)
Table 45. Global PD-1 and PD-L1 Inhibitors Sales (L) by Application (2015-2020)
Table 46. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
Table 47. Global PD-1 and PD-L1 Inhibitors Sales Growth Rate by Application (2015-2020)
Table 48. Merck PD-1 and PD-L1 Inhibitors Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 51. Merck Main Product
Table 52. Merck Recent Development
Table 53. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Corporation Information
Table 54. Bristol-Myers Squibb Corporation Information
Table 55. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 56. Bristol-Myers Squibb Main Product
Table 57. Bristol-Myers Squibb Recent Development
Table 58. Roche PD-1 and PD-L1 Inhibitors Corporation Information
Table 59. Roche Corporation Information
Table 60. Roche PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 61. Roche Main Product
Table 62. Roche Recent Development
Table 63. AstraZeneca PD-1 and PD-L1 Inhibitors Corporation Information
Table 64. AstraZeneca Corporation Information
Table 65. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 66. AstraZeneca Main Product
Table 67. AstraZeneca Recent Development
Table 68. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Corporation Information
Table 69. Ono Pharmaceutical Corporation Information
Table 70. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 71. Ono Pharmaceutical Main Product
Table 72. Ono Pharmaceutical Recent Development
Table 73. Regeneron PD-1 and PD-L1 Inhibitors Corporation Information
Table 74. Regeneron Corporation Information
Table 75. Regeneron PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 76. Regeneron Main Product
Table 77. Regeneron Recent Development
Table 78. Innovent PD-1 and PD-L1 Inhibitors Corporation Information
Table 79. Innovent Corporation Information
Table 80. Innovent PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 81. Innovent Main Product
Table 82. Innovent Recent Development
Table 83. Hengrui Medicine PD-1 and PD-L1 Inhibitors Corporation Information
Table 84. Hengrui Medicine Corporation Information
Table 85. Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 86. Hengrui Medicine Main Product
Table 87. Hengrui Medicine Recent Development
Table 88. Junshi Biosciences PD-1 and PD-L1 Inhibitors Corporation Information
Table 89. Junshi Biosciences Corporation Information
Table 90. Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 91. Junshi Biosciences Main Product
Table 92. Junshi Biosciences Recent Development
Table 93. Merck KGaA PD-1 and PD-L1 Inhibitors Corporation Information
Table 94. Merck KGaA Corporation Information
Table 95. Merck KGaA PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 96. Merck KGaA Main Product
Table 97. Merck KGaA Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. PD-1 and PD-L1 Inhibitors Distributors List
Table 101. PD-1 and PD-L1 Inhibitors Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global PD-1 and PD-L1 Inhibitors Sales (L) Forecast by Type (2021-2026)
Table 106. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Type (2021-2026)
Table 107. Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global PD-1 and PD-L1 Inhibitors Sales (L) Forecast by Application (2021-2026)
Table 110. Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global PD-1 and PD-L1 Inhibitors Sales (L) Forecast by Region (2021-2026)
Table 112. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Region (2021-2026)
Table 113. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 1. Global PD-1 and PD-L1 Inhibitors Sales (L) Growth Rate Comparison by Type (2015-2026)
Table 2. Global PD-1 and PD-L1 Inhibitors Sales (L) Comparison by Application: 2020 VS 2026
Table 3. Global PD-1 and PD-L1 Inhibitors Market Size by Type (L) (US$ Million) (2020 VS 2026)
Table 4. Global Key PD-1 and PD-L1 Inhibitors Manufacturers Covered in This Study
Table 5. Global PD-1 and PD-L1 Inhibitors Sales (L) by Manufacturers (2015-2020)
Table 6. Global PD-1 and PD-L1 Inhibitors Sales Share by Manufacturers (2015-2020)
Table 7. Global PD-1 and PD-L1 Inhibitors Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global PD-1 and PD-L1 Inhibitors Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market PD-1 and PD-L1 Inhibitors Average Price (USD/ml) of Key Manufacturers (2015-2020)
Table 10. Manufacturers PD-1 and PD-L1 Inhibitors Sales Sites and Area Served
Table 11. Manufacturers PD-1 and PD-L1 Inhibitors Product Types
Table 12. Global PD-1 and PD-L1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global PD-1 and PD-L1 Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-1 and PD-L1 Inhibitors as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key PD-1 and PD-L1 Inhibitors Players
Table 16. Global PD-1 and PD-L1 Inhibitors Sales (L) by Region (2015-2020)
Table 17. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2015-2020)
Table 18. Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) by Region (2015-2020)
Table 19. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2015-2020)
Table 20. North America PD-1 and PD-L1 Inhibitors Sales by Country (2015-2020) (L)
Table 21. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2015-2020)
Table 22. North America PD-1 and PD-L1 Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 23. North America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2015-2020)
Table 24. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2015-2020) (L)
Table 25. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2015-2020)
Table 26. Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Region (2015-2020) (L)
Table 29. Asia Pacific PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2015-2020)
Table 32. Latin America PD-1 and PD-L1 Inhibitors Sales by Country (2015-2020) (L)
Table 33. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2015-2020)
Table 34. Latin America PD-1 and PD-L1 Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country (2015-2020) (L)
Table 37. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2015-2020)
Table 40. Global PD-1 and PD-L1 Inhibitors Sales (L) by Type (2015-2020)
Table 41. Global PD-1 and PD-L1 Inhibitors Sales Share by Type (2015-2020)
Table 42. Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) by Type (2015-2020)
Table 43. Global PD-1 and PD-L1 Inhibitors Revenue Share by Type (2015-2020)
Table 44. Global PD-1 and PD-L1 Inhibitors Price (USD/ml) by Type (2015-2020)
Table 45. Global PD-1 and PD-L1 Inhibitors Sales (L) by Application (2015-2020)
Table 46. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
Table 47. Global PD-1 and PD-L1 Inhibitors Sales Growth Rate by Application (2015-2020)
Table 48. Merck PD-1 and PD-L1 Inhibitors Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 51. Merck Main Product
Table 52. Merck Recent Development
Table 53. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Corporation Information
Table 54. Bristol-Myers Squibb Corporation Information
Table 55. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 56. Bristol-Myers Squibb Main Product
Table 57. Bristol-Myers Squibb Recent Development
Table 58. Roche PD-1 and PD-L1 Inhibitors Corporation Information
Table 59. Roche Corporation Information
Table 60. Roche PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 61. Roche Main Product
Table 62. Roche Recent Development
Table 63. AstraZeneca PD-1 and PD-L1 Inhibitors Corporation Information
Table 64. AstraZeneca Corporation Information
Table 65. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 66. AstraZeneca Main Product
Table 67. AstraZeneca Recent Development
Table 68. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Corporation Information
Table 69. Ono Pharmaceutical Corporation Information
Table 70. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 71. Ono Pharmaceutical Main Product
Table 72. Ono Pharmaceutical Recent Development
Table 73. Regeneron PD-1 and PD-L1 Inhibitors Corporation Information
Table 74. Regeneron Corporation Information
Table 75. Regeneron PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 76. Regeneron Main Product
Table 77. Regeneron Recent Development
Table 78. Innovent PD-1 and PD-L1 Inhibitors Corporation Information
Table 79. Innovent Corporation Information
Table 80. Innovent PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 81. Innovent Main Product
Table 82. Innovent Recent Development
Table 83. Hengrui Medicine PD-1 and PD-L1 Inhibitors Corporation Information
Table 84. Hengrui Medicine Corporation Information
Table 85. Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 86. Hengrui Medicine Main Product
Table 87. Hengrui Medicine Recent Development
Table 88. Junshi Biosciences PD-1 and PD-L1 Inhibitors Corporation Information
Table 89. Junshi Biosciences Corporation Information
Table 90. Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 91. Junshi Biosciences Main Product
Table 92. Junshi Biosciences Recent Development
Table 93. Merck KGaA PD-1 and PD-L1 Inhibitors Corporation Information
Table 94. Merck KGaA Corporation Information
Table 95. Merck KGaA PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million US$), Price (USD/ml) and Gross Margin (2015-2020)
Table 96. Merck KGaA Main Product
Table 97. Merck KGaA Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. PD-1 and PD-L1 Inhibitors Distributors List
Table 101. PD-1 and PD-L1 Inhibitors Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global PD-1 and PD-L1 Inhibitors Sales (L) Forecast by Type (2021-2026)
Table 106. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Type (2021-2026)
Table 107. Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global PD-1 and PD-L1 Inhibitors Sales (L) Forecast by Application (2021-2026)
Table 110. Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global PD-1 and PD-L1 Inhibitors Sales (L) Forecast by Region (2021-2026)
Table 112. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Region (2021-2026)
Table 113. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Picture of PD-1 and PD-L1 Inhibitors
Figure 2. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type: 2020 VS 2026
Figure 3. PD-1 Inhibitors Product Picture
Figure 4. PD-L1 Inhibitors Product Picture
Figure 5. Global PD-1 and PD-L1 Inhibitors Consumption Market Share by Application: 2020 VS 2026
Figure 6. Solid Tumors
Figure 7. Blood-related Tumors
Figure 8. Global PD-1 and PD-L1 Inhibitors Market Size 2015-2026 (US$ Million)
Figure 9. Global PD-1 and PD-L1 Inhibitors Sales Capacity (L) (2015-2026)
Figure 10. Global PD-1 and PD-L1 Inhibitors Market Size Market Share by Region: 2020 Versus 2026
Figure 11. PD-1 and PD-L1 Inhibitors Sales Share by Manufacturers in 2020
Figure 12. Global PD-1 and PD-L1 Inhibitors Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by PD-1 and PD-L1 Inhibitors Revenue in 2019
Figure 14. PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2015-2020)
Figure 16. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2019
Figure 17. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2015-2020)
Figure 18. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region in 2019
Figure 19. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2019
Figure 20. North America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2019
Figure 21. U.S. PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 22. U.S. PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 24. Canada PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2019
Figure 26. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2019
Figure 27. Germany PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 28. Germany PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 30. France PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 32. U.K. PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 34. Italy PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 36. Russia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2019
Figure 38. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue Market Share by Region in 2019
Figure 39. China PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 40. China PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 42. Japan PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 44. South Korea PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 46. India PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 48. Australia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 50. Taiwan PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 52. Indonesia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 54. Thailand PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 56. Malaysia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 58. Philippines PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 60. Vietnam PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2019
Figure 62. Latin America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2019
Figure 63. Mexico PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 64. Mexico PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 66. Brazil PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 68. Argentina PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2019
Figure 70. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2019
Figure 71. Turkey PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 72. Turkey PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Saudi Arabia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 74. Saudi Arabia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. UAE PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 76. UAE PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Sales Market Share of PD-1 and PD-L1 Inhibitors by Type (2015-2020)
Figure 78. Sales Market Share of PD-1 and PD-L1 Inhibitors by Type in 2019
Figure 79. Revenue Share of PD-1 and PD-L1 Inhibitors by Type (2015-2020)
Figure 80. Revenue Market Share of PD-1 and PD-L1 Inhibitors by Type in 2019
Figure 81. Global PD-1 and PD-L1 Inhibitors Sales Growth by Type (2015-2020) (L)
Figure 82. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
Figure 83. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2019
Figure 84. Global Revenue Share of PD-1 and PD-L1 Inhibitors by Application (2015-2020)
Figure 85. Global Revenue Share of PD-1 and PD-L1 Inhibitors by Application in 2020
Figure 86. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Ono Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Innovent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Hengrui Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Junshi Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Price Trend of Key Raw Materials
Figure 97. Manufacturing Cost Structure of PD-1 and PD-L1 Inhibitors
Figure 98. Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
Figure 99. PD-1 and PD-L1 Inhibitors Industrial Chain Analysis
Figure 100. Channels of Distribution
Figure 101. Distributors Profiles
Figure 102. Porter's Five Forces Analysis
Figure 103. North America PD-1 and PD-L1 Inhibitors Sales (L) and Growth Rate Forecast (2021-2026)
Figure 104. North America PD-1 and PD-L1 Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Europe PD-1 and PD-L1 Inhibitors Sales (L) and Growth Rate Forecast (2021-2026)
Figure 106. Europe PD-1 and PD-L1 Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Latin America PD-1 and PD-L1 Inhibitors Sales (L) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America PD-1 and PD-L1 Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales (L) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Asia Pacific PD-1 and PD-L1 Inhibitors Sales (L) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed
Figure 1. Picture of PD-1 and PD-L1 Inhibitors
Figure 2. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type: 2020 VS 2026
Figure 3. PD-1 Inhibitors Product Picture
Figure 4. PD-L1 Inhibitors Product Picture
Figure 5. Global PD-1 and PD-L1 Inhibitors Consumption Market Share by Application: 2020 VS 2026
Figure 6. Solid Tumors
Figure 7. Blood-related Tumors
Figure 8. Global PD-1 and PD-L1 Inhibitors Market Size 2015-2026 (US$ Million)
Figure 9. Global PD-1 and PD-L1 Inhibitors Sales Capacity (L) (2015-2026)
Figure 10. Global PD-1 and PD-L1 Inhibitors Market Size Market Share by Region: 2020 Versus 2026
Figure 11. PD-1 and PD-L1 Inhibitors Sales Share by Manufacturers in 2020
Figure 12. Global PD-1 and PD-L1 Inhibitors Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by PD-1 and PD-L1 Inhibitors Revenue in 2019
Figure 14. PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2015-2020)
Figure 16. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2019
Figure 17. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2015-2020)
Figure 18. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region in 2019
Figure 19. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2019
Figure 20. North America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2019
Figure 21. U.S. PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 22. U.S. PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 23. Canada PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 24. Canada PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2019
Figure 26. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2019
Figure 27. Germany PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 28. Germany PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. France PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 30. France PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. U.K. PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 32. U.K. PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Italy PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 34. Italy PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Russia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 36. Russia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Asia Pacific PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2019
Figure 38. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue Market Share by Region in 2019
Figure 39. China PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 40. China PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Japan PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 42. Japan PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. South Korea PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 44. South Korea PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. India PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 46. India PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Australia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 48. Australia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Taiwan PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 50. Taiwan PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Indonesia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 52. Indonesia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Thailand PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 54. Thailand PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Malaysia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 56. Malaysia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Philippines PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 58. Philippines PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Vietnam PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 60. Vietnam PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2019
Figure 62. Latin America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2019
Figure 63. Mexico PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 64. Mexico PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Brazil PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 66. Brazil PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Argentina PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 68. Argentina PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2019
Figure 70. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2019
Figure 71. Turkey PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 72. Turkey PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Saudi Arabia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 74. Saudi Arabia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. UAE PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (L)
Figure 76. UAE PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Sales Market Share of PD-1 and PD-L1 Inhibitors by Type (2015-2020)
Figure 78. Sales Market Share of PD-1 and PD-L1 Inhibitors by Type in 2019
Figure 79. Revenue Share of PD-1 and PD-L1 Inhibitors by Type (2015-2020)
Figure 80. Revenue Market Share of PD-1 and PD-L1 Inhibitors by Type in 2019
Figure 81. Global PD-1 and PD-L1 Inhibitors Sales Growth by Type (2015-2020) (L)
Figure 82. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
Figure 83. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2019
Figure 84. Global Revenue Share of PD-1 and PD-L1 Inhibitors by Application (2015-2020)
Figure 85. Global Revenue Share of PD-1 and PD-L1 Inhibitors by Application in 2020
Figure 86. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Ono Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Innovent Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Hengrui Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Junshi Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Price Trend of Key Raw Materials
Figure 97. Manufacturing Cost Structure of PD-1 and PD-L1 Inhibitors
Figure 98. Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
Figure 99. PD-1 and PD-L1 Inhibitors Industrial Chain Analysis
Figure 100. Channels of Distribution
Figure 101. Distributors Profiles
Figure 102. Porter's Five Forces Analysis
Figure 103. North America PD-1 and PD-L1 Inhibitors Sales (L) and Growth Rate Forecast (2021-2026)
Figure 104. North America PD-1 and PD-L1 Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Europe PD-1 and PD-L1 Inhibitors Sales (L) and Growth Rate Forecast (2021-2026)
Figure 106. Europe PD-1 and PD-L1 Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Latin America PD-1 and PD-L1 Inhibitors Sales (L) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America PD-1 and PD-L1 Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales (L) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Asia Pacific PD-1 and PD-L1 Inhibitors Sales (L) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed
